Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF.

Hum Vaccin Immunother. 2018 Feb 1;14(2):495-499. doi: 10.1080/21645515.2017.1403705. Epub 2017 Dec 21. Review.

2.

Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.

Mwenda JM, Burke RM, Shaba K, Mihigo R, Tevi-Benissan MC, Mumba M, Biey JN, Cheikh D, Poy MSc A, Zawaira FR, Aliabadi N, Tate JE, Hyde T, Cohen AL, Parashar UD.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1192-1196. doi: 10.15585/mmwr.mm6643a7.

3.

Rotavirus vaccination: a concise review.

Vesikari T.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:57-63. doi: 10.1111/j.1469-0691.2012.03981.x. Epub 2012 Aug 6. Review.

4.

Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.

Cui S, Tobe RG, Mo X, Liu X, Xu L, Li S.

BMC Infect Dis. 2016 Nov 15;16(1):677. doi: 10.1186/s12879-016-2013-1. Erratum in: BMC Infect Dis. 2018 Sep 27;18(1):487.

5.

Performance of rotavirus vaccines in developed and developing countries.

Jiang V, Jiang B, Tate J, Parashar UD, Patel MM.

Hum Vaccin. 2010 Jul;6(7):532-42. Review.

6.

Rotavirus vaccination in Central American children.

Ulloa-Gutierrez R, Avila-Aguero ML.

Expert Rev Vaccines. 2014 Jun;13(6):687-90. doi: 10.1586/14760584.2014.905747. Epub 2014 Apr 7.

PMID:
24702467
7.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
8.

Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.

Lepage P, Vergison A.

Expert Opin Biol Ther. 2007 Dec;7(12):1881-92. Review.

PMID:
18034653
9.

Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward.

Parashar UD, Johnson H, Steele AD, Tate JE.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S91-5. doi: 10.1093/cid/civ1015.

PMID:
27059361
10.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
11.

Rotavirus vaccines: a story of success.

Kollaritsch H, Kundi M, Giaquinto C, Paulke-Korinek M.

Clin Microbiol Infect. 2015 Aug;21(8):735-43. doi: 10.1016/j.cmi.2015.01.027. Epub 2015 Feb 11. Review.

12.

Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.

Kirkwood CD, Boniface K, Barnes GL, Bishop RF.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S48-53. doi: 10.1097/INF.0b013e3181fefd90.

PMID:
21183840
13.

Implementing rotavirus vaccination in Asia.

Santosham M, Nelson EA, Bresee JS.

Vaccine. 2007 Nov 1;25(44):7711-6. Epub 2007 Aug 22.

PMID:
17881099
14.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Erratum in: Pediatr Infect Dis J. 2011 Oct; 30(10):916.

PMID:
21183837
15.

Rotavirus vaccine: a cost effective control measure for India.

Kumar A, Goel MK, Jain RB, Khanna P, Vibha V.

Hum Vaccin Immunother. 2012 Apr;8(4):501-4. Review.

PMID:
23071989
16.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
17.

Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.

Pawinski R, Debrus S, Delem A, Smolenov I, Suryakiran PV, Han HH.

J Infect Dis. 2010 Sep 1;202 Suppl:S80-6. doi: 10.1086/653547.

PMID:
20684722
18.

Building laboratory capacity to support the global rotavirus surveillance network.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 24;62(20):409-12.

19.

Mucosal Immunity and acute viral gastroenteritis.

Rose MA.

Hum Vaccin Immunother. 2014;10(7):2112-4. doi: 10.4161/hv.29605. Review.

20.

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.

Tate JE, Ngabo F, Donnen P, Gatera M, Uwimana J, Rugambwa C, Mwenda JM, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S208-12. doi: 10.1093/cid/civ1016.

PMID:
27059358

Supplemental Content

Support Center